5th Neuroimmunology Drug Development Summit

Hello,

As the role of the immune system in neurological disease pathophysiology becomes increasingly apparent, comes the 5th Neuroimmunology Drug Development Summit (April 25-27, Boston), an exclusive forum that will unite established and emerging innovators in the expanding neuroimmunology space, providing actionable takeaways across neuroglia modeling, novel neuroimmunological targeting and neuroinflammatory biomarker discovery.

View your copy of the industry-dedicated 2023 program packed with brand-new speakers showcasing the latest innovations in neuroimmunology research from the likes of Novartis, Roche, Biogen, Genentech, Sanofi, Muna Therapeutics, Bristol Myers Squibb, Takeda and more.

New and unmissable Insights for 2023:

• Exclusive content on discovering novel iPSC-derived microglia and astrocytes and uncovering neuroinflammatory mechanisms across numerous neurological indications, including Alzheimer’s, Multiple Sclerosis, Parkinson’s, Amyotrophic Lateral Sclerosis, and Traumatic Brain Injury
• A comprehensive pre-conference workshop day comprising specialist-led content to inform selection of novel neuroimmune targets and clinically detect neuroinflammatory modulation
• Thought-provoking discussions to decipher the most effective in vitro and in vivo models to recapitulate all hallmarks of neuroglia
• Thorough analyses of discovery through to clinical development of neuroinflammatory biomarkers to enhance sensitivity and translatability

Don’t miss your critical opportunity to attend the only industry-dedicated conference dedicated to translating neuroimmunological targets and neuroinflammatory biomarkers to revolutionize neurological drug development.

We hope you can join us in Boston in April!

Kind regards,

Ellie

Ellie Rapps
Program Director – Neuroimmunology Drug Development Summit
Hanson Wade